192 related articles for article (PubMed ID: 19127085)
1. Venous thromboembolism prevention in patients with heart failure: an often neglected issue.
Imberti D; Pierfranceschi MG; Falciani M; Prisco D
Pathophysiol Haemost Thromb; 2008; 36(2):69-74. PubMed ID: 19127085
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of venous thromboembolism during pregnancy.
Weitz JI
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S22-6. PubMed ID: 19213066
[TBL] [Abstract][Full Text] [Related]
3. In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in Internal Medicine. Findings from a multicenter, prospective study.
Gussoni G; Campanini M; Silingardi M; Scannapieco G; Mazzone A; Magni G; Valerio A; Iori I; Ageno W;
Thromb Haemost; 2009 May; 101(5):893-901. PubMed ID: 19404543
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.
Dentali F; Riva N; Gianni M; Malato A; Bozzato S; Bernasconi M; Tuttolomondo A; Romano A; Pinto A; Siragusa S; Ageno W
Thromb Res; 2008; 123(1):67-71. PubMed ID: 18328541
[TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
[TBL] [Abstract][Full Text] [Related]
6. [Venous thromboembolism prophylaxis in internal medicine].
Malý J; Widimský J; Dulícek P
Vnitr Lek; 2009 Mar; 55(3):190-5. PubMed ID: 19378845
[TBL] [Abstract][Full Text] [Related]
7. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
9. Risk stratification and venous thromboprophylaxis in hospitalized medical and cancer patients.
Prandoni P; Samama MM
Br J Haematol; 2008 May; 141(5):587-97. PubMed ID: 18422787
[TBL] [Abstract][Full Text] [Related]
10. [Thromboembolic prophylaxis in hospitalized medical patients].
Braekkan S; Grimsgaard S; Hansen JB
Tidsskr Nor Laegeforen; 2007 May; 127(9):1177-80. PubMed ID: 17479133
[TBL] [Abstract][Full Text] [Related]
11. Venous thromboembolic disease in congestive heart failure.
Dean SM; Abraham W
Congest Heart Fail; 2010; 16(4):164-9. PubMed ID: 20662869
[TBL] [Abstract][Full Text] [Related]
12. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
13. Unanswered questions in venous thromboembolism.
Weitz JI
Thromb Res; 2009; 123 Suppl 4():S2-S10. PubMed ID: 19303498
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of venous thromboembolism in cardiorespiratory and infectious disease.
Alikhan R; Spyropoulos AC
Am J Med; 2008 Nov; 121(11):935-42. PubMed ID: 18954836
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
16. Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Merli G; Spyropoulos AC; Caprini JA
Ann Surg; 2009 Aug; 250(2):219-28. PubMed ID: 19638915
[TBL] [Abstract][Full Text] [Related]
17. Real-world economic burden of venous thromboembolism and antithrombotic prophylaxis in medical inpatients.
Gussoni G; Foglia E; Frasson S; Casartelli L; Campanini M; Bonfanti M; Colombo F; Porazzi E; Ageno W; Vescovo G; Mazzone A;
Thromb Res; 2013 Jan; 131(1):17-23. PubMed ID: 23141845
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of thrombotic risk factors: the difficulty in using clinical trials to develop a risk assessment model.
Laporte S; Mismetti P
Crit Care Med; 2010 Feb; 38(2 Suppl):S10-7. PubMed ID: 20083908
[TBL] [Abstract][Full Text] [Related]
19. Should all acutely ill medical patients be treated with antithrombotic drugs? A review of the interventional trials.
Violi F; Perri L; Loffredo L
Thromb Haemost; 2013 Apr; 109(4):589-95. PubMed ID: 23426236
[TBL] [Abstract][Full Text] [Related]
20. Prophylaxis and treatment of venous thromboembolism in cancer patients: a review.
Ansell JE
Am J Clin Oncol; 2009 Aug; 32(4 Suppl):S8-S12. PubMed ID: 19654482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
